Cytochrome P450 2C9-indiiced angiogenesis is dependent on EphB4

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 28, Issue 6, 2008, Pages 1123-1129

  Webler, Anke C ^a   Popp, Rüdiger ^a   Korff, Thomas ^c   Michaelis, U Ruth ^a   Urbich, Carmen ^b   Busset, Rudi ^a   Fleming, Ingrid ^a,b  

^a Institut für Kardiovaskuläre Physiologie   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Akt; Angiogenesis; Epoxyeicosatrienoic acid; siRNA

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CYTOCHROME P450 2C9; EPHRIN RECEPTOR B4; MATRIGEL; OLIGONUCLEOTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA; 11,12 EPOXY 5,8,14 EICOSATRIENOIC ACID; 11,12-EPOXY-5,8,14-EICOSATRIENOIC ACID; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; ANTISENSE OLIGONUCLEOTIDE; CHROMONE DERIVATIVE; CYTOCHROME P 450 CYP2C SUBFAMILY; CYTOCHROME P-450 CYP2C SUBFAMILY; CYTOCHROME P450; DIHOMO GAMMA LINOLENIC ACID; DRUG DERIVATIVE; ENZYME INHIBITOR; MORPHOLINE DERIVATIVE; VASODILATOR AGENT;

ANGIOGENESIS; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; CELL INVASION; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; FEMALE; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO CULTURE; MESENTERIC ARTERY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULARIZATION; ANIMAL; AORTA; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DRUG EFFECT; GENETICS; HUMAN; MALE; METABOLISM; MOUSE STRAIN; PHYSIOLOGY; SIGNAL TRANSDUCTION; SWINE; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

1-PHOSPHATIDYLINOSITOL 3-KINASE; 8,11,14-EICOSATRIENOIC ACID; ANIMALS; AORTA; CELLS, CULTURED; CHROMONES; CYTOCHROME P-450 ENZYME SYSTEM; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MORPHOLINES; NEOVASCULARIZATION, PHYSIOLOGIC; OLIGONUCLEOTIDES, ANTISENSE; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPHB4; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SWINE; UMBILICAL VEINS; VASODILATOR AGENTS;

EID: 44849087722     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.107.161190     Document Type: Article

References (39)

1. Larsen BT, Campbell WB, Gutterman DD. Beyond vasodilatation: nonvasomotor roles of epoxyeicosatrienoic acids in the cardiovascular system. Trends Pharmacol Sci. 2007;28:32-38.
2. Spector AA, Norris AW. Action of epoxyeicosatrienoic acids on cellular function. Am J Physiol Cell Physiology. 2007;292:C996 C1012.
3. Campbell WB, Gebremedhin D, Pratt PF, Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res. 1996;78:415-423.
4. Fisslthaler B, Popp R, Kiss I., Potente M, Harder DR, Fleming I, Busse R. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature. 1999;401:493-497.
5. Michaelis UR, Fleming I, From endothelium-derived hyperpolarizing factor (EDHF) to angiogenesis: epoxyeicosatrienoic acids (EETs) and cell signaling. Pharmacol Ther. 2006;111:584-595.
6. Chen J-K, Capdevila J, Harris RC. Heparin-binding EGF-like growth factor mediates the biological effects of P450 arachidonate epoxygenase metabolites in epithelial cells. Proc Natl Acad Sci USA. 2002;99: 6029-6034.
7. Michaelis UR, Fisslthaler B, Medhora M, Harder D, Fleming I, Busse R. Cytochrome P450 2C9-derived epoxyeicosatrienoic acids induce angiogenesis via cross-talk with die epidermal growth factor receptor (EGFR). FASEB J. 2003;17:770-772.
8. Potente M, Michaelis UR, Fisslthaler B, Busse R, Fleming I. Cytochrome P450 2C9-induced endodielial cell proliferation involves induction of mitogen-activated protein (MAP) kinase phosphatase-1, inhibition of the c-Jun N-terminal kinase, and up-regulation of cyclin Dl. J Biol Chem. 2002;277:15671-15676.
9. Potente M, Fisslthaler B, Busse R, Fleming I. 11,12-Epoxyeicosatrienoic acid-induced inhibition of FOXO factors promotes endothelial proliferation by down-regulating p27Kipl. J Biol Chem. 2003;278: 29619-29625.
10. Kuijper S, Turner CJ, Adams RH. Regulation of angiogenesis by Ephephrin interactions. Trends Cardiovasc Med. 2007;17:145-151.
11. Gerety SS, Wang HU, Chen ZF, Anderson D1. Symmetrical mutant phenotypes of die receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Mol Cell. 1999;4:403-414.
12. Shin D, Garcia-Cardena G, Hayashi S, Gerety S, Asahara T, Stavrakis G, Isner J, Folkman J, Gimbrone MA Jr, Anderson DJ. Expression of ephrin.B2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization. Dev Biol. 2001;230:139-150.
13. Kojima T, Chung TY, Chang JH, Sayegh R, Casanova FH, Azar DT. Comparison of EphA receptor tyrosine kinases and ephrinA ligand. expression to EphB-ephrinB in vascularized corneas. Cornea. 2007;26: 569-578.
14. Taylor AC, Murfee WL, Peirce SM. EphB4 expression along adult rat microvascular networks: EphB4 is more than a venous specific marker. Microcirculation. 2007;14:253-267.
15. Gauthier KM, Deeter C, Krishna UM, Reddy YK, Bondleia M, Falck JR, Campbell WB. 14, 15-Epoxyeicosa-5(Z)-enoic acid: a selective epoxyeicosatrienoic acid antagonist that inhibits endothelium-dependent hyperpolarization and relaxation in coronary arteries. Circ Res. 2002;90: 1028-1036.
16. Busse R, Lamontagne D. Endothelium-derived bradykinin is responsible for the increase in calcium produced by angiotensin-converting enzyme inhibitors in human endodielial cells. Naunyn Schmiedebergs Arch Pharmacol. 1991;344:126-129.
17. Popp R, Bauersachs J, Hecker M, Fleming I, Busse R. A transferable, β-naphthoflavone-inducible, hyperpolarizing factor is synthesized by native and cultured porcine coronary endothelial cells. J Physiol (Land). 1996;497:699-709.
18. Fleming I, Fisslthaler B, Dixit M, Busse R. Role of PECAM-I in the shear-stress-induced activation of Akt and the endothelial nitric oxide syndiase (eNOS) in endothelial cells. J Cell. Sci. 2005;118:4103-4111.
19. Michaelis UR, Fissldialer B, Barbosa-Sicard E, Falck JR, Fleming I, Busse R. Cytochrome P450 epoxygenases 2C8 and 2C9 are implicated in hypoxia-induced endothelial cell migration and angiogenesis. J Cell Sci. 2005;118:5489-5498.
20. Xia G, Kumar SR, Masood R, Koss M, Tempieman C, Quinn D, Zhu S, Reddy R, Krasnoperov V, Gill. PS. Up-regulation of EphB4 in mesothelioma and its biological significance. Clin Cancer Res. 2005; 11: 4305-4315.
21. Bruhl T, Urbich C, Aicher D, cker-Palmer A, Zeiher AM, Dimmeler S. Homeobox A9 transcriptionally regulates the EphB4 receptor to modulate endothelial cell migration and tube formation. Circ Res. 2004;94: 743-751.
22. Korff T, Dandekar G, Pfaff D, Fuller T, Goettsch W, Morawietz H, Schaffner F, Augustin HG. Endodielial ephrinB2 is controlled, by microenvironmental determinants and associates context-dependently with CD31. Arterioscler Thromb Vase Biol. 2006;26:468-474.
23. Korff T, Augustin HG. Tensional forces in fibrillar extracellular matrices control directional capillary sprouting. J Cell. Sci.1999;112:3249-3258.
24. Wang HU, Chen ZF, Anderson DJ. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell. 1998;93:741-753.
25. Fisslthaler B, Hinsch N, Chataigneau T, Popp R, Kiss L, Busse R, Fleming I. Nifedipine increases cytochrome P4502C expression and endothelium-derived hyperpolarizing factor-mediated responses in coronary arteries. Hypertension. 2000;36:270-275.
26. Medhora M, Daniels J, Mundey K, Fisslthaler B, Busse R, Jacobs ER, Harder DR. Epoxygenase-driven angiogenesis in human lung microvascular endothelial cells. Am J Physiol Heart and Circulatory Physiology. 2003;284:H215 H224.
27. Michaelis UR, Falck JR, Schmidt R, Busse R, Fleming I. Cytochrome P4502C9-derived epoxyeicosatrienoic acids induce the expression of cyclooxygenase-2 in endothelial cells. Arterioscler Thromb Vasc Biol. 2005;25:321-326.
28. Munzenmaier DH, Harder DR. Cerebral microvascular endothelial cell tube formation: role of astrocytic epoxyeicosatrienoic acid release. Am J Physiol Heart Circ Physiol. 2000;278:H1163-H1167.
29. Zhang B, Cao H, Rao GN. Fibroblast growtii factor-2 is a downstream mediator of phosphatidylinositol 3-kinase-Akt signaling in 14, 15epoxyeicosatrienoic acid-induced angiogenesis. J Biol Chem. 2006;281: 905-914.
30. Jiang JG, Chen CL, Card JW, Yang S, Chen JX, Fu XN, Ning YG, Xiao X, Zeldin DC, Wang DW. Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors. Cancer Res. 2005;65:4707-4715.
31. Wong PY, Lai PS, Falck JR. Mechanism and signal transduction of 14 (R), 15 (S)-epoxyeicosatrienoic acid (14,15-EET) binding in guinea pig monocytes. Prostaglandins Other Lipid Médiat. 2000;62:321-333.
32. Snyder GD, Krishna UM, Falck JR, Spector AA. Evidence for a membrane site of action for 14,15-EET on expression of aromatase in vascular smooth muscle. Am J Physiol Heart Circ Physiol. 2002;283: H1936-H1942.
33. Chen JK, Capdevila J, Harris RC. Cytochrome P450 epoxygenase metabolism of arachidonic acid inhibits apoptosis. Mol Cell. Biol. 2001;21: 6322-6331.
34. Fleming I, Fissldialer B, Michaelis UR, Kiss L, Popp R, Busse R. The coronary endothelium-derived hyperpolarizing factor (EDHF) stimulates multiple signalling pathways and proliferation in vascular cells. Pflugers Arch. 2001;442:511-518.
35. Füller T, Korff T, Kilián A, Dandekar G, Augustin HG. Forward Eph.B4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells. J Cell Sci. 2003;116:2461-2470.
36. Salvucci O, De La Luz SM, Martina JA, McCormick PJ, Tosato G. EphB2 and Eph.B4 receptors forward signaling promotes SDF-I-induced endothelial cell Chemotaxis and branching remodeling. Blood. 2006;108: 2914-2922.
37. Erber R, Eicheisbacher U, Powajbo V, Korn T, Djonov V, Lin J, Hammes HP, Grobholz R, Ullrich A, Vajkoczy P. EphB4 controls blood vascular morphogenesis during postnatal angiogenesis. EMBO J. 2006;25: 628-641.
38. Hall SM, Hislop AA, Haworth SG. Origin, differentiation, and maturation of human pulmonary veins. Am J Respir Cell Mol Biol. 2002;26:333-340.
39. Diehl S, Bruno R, Wilkinson GA, Loose DA, Wilting J, Schweigerer L, Klein R. Altered expression patterns of EphrinB2 and EphB2 in human umbilical vessels and congenitol venous malformations. Pediatr Res. 2005;57:537-544.